The Minimal Residual Disease in Non-Hodgkin's Lymphomas: From the Laboratory to the Clinical Practice

Minimal residual disease (MRD) in non-Hodgkin's lymphomas (NHLs) still represents matter of interest and debate: indeed, the new available treatments offer higher rates of complete responses and MRD negativity than in the past, with a positive impact on the long-term survival. Furthermore, the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: Galimberti, Sara, Genuardi, Elisa, Mazziotta, Francesco, Iovino, Lorenzo, Morabito, Fortunato, Grassi, Susanna, Ciabatti, Elena, Guerrini, Francesca, Petrini, Mario
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6606710/
https://ncbi.nlm.nih.gov/pubmed/31293969
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00528
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados